Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30355339 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TTRTSHR | |
| SCHEMBL8467681 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TTRTSHR | |
| SCHEMBL8467676 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TTRTSHR | |
| SCHEMBL367055 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TTRTSHR | |
| SCHEMBL8467677 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TTRTSHR | |
| SCHEMBL20242200 | 0.97 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL30229416 | 0.97 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL20241379 | 0.97 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL7751979 | 0.97 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL30229481 | 0.94 | ALDH1A1 (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017833-A1 | MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF | INT FLAVORS & FRAGRANCES INC (US) | 2025-01-16 | — | — | US | disclosed |
| US-20250009623-A1 | NOVEL 2,2'-(OCTYLIMINO)BIS[ETHANOL] COMPOSITIONS AND USES THEREOF | INT FLAVORS & FRAGRANCES INC (US) | 2025-01-09 | — | — | US | disclosed |
| US-20120015009-A9 | Multi-phased personal care composition comprising a blooming perfume composition | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | disclosed |
| US-20070280976-A1 | Multi-phased personal care composition comprising a blooming perfume composition | THE PROCTER & GAMBLE COMPANY | 2007-12-06 | — | — | US | disclosed |
| EP-1417372-A1 | FRAGRANCE COMPOSITIONS FOR CO2 DRY CLEANING PROCESS | Symrise GmbH & Co. KG (DE) | 2004-05-12 | — | — | EP | disclosed |
| WO-2003010381-A1 | FRAGRANCE COMPOSITIONS FOR CO2 DRY CLEANING PROCESS | SYMRISE GMBH & CO. KG (DE) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250017833-A1 | MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF | MAL2, LPO, SMURF1 | ALDH1A1 235/4885TTR 991/4885TSHR 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.